ScreenCell® logo

Our clinical trials

Our clinical trials aim to demonstrate the clinical utility of circulating tumor cells in the care pathway of cancer patients, using ScreenCell® technology.

African American person donating blood while listening to music with other patients in background Donor sitting on a recliner with an IV in arm

Filter by

Type of cancer

Select a type of cancer

In progress

 

Analysis of Circulating Tumor Cells (CTCs) in Patients with Metastatic Melanoma Before and During Systemic Treatment

Type of cancer:

  • Melanoma

Trial status:

  • Analysis in progress
View clinical trial

In progress

 

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device (PROBE-CTC)

Type of cancer:

  • Breast cancer

Trial status:

  • Active recruitment
View clinical trial

Completed

 

Evaluation of Circulating Tumor Cells (CTCs) by the ScreenCell® device in breast cancer: validation of biomarkers

Type of cancer:

  • Metastatic breast cancer

Trial status:

  • Completed
View clinical trial

Completed

 

Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology (EXPEVIVO-CTC)

Type of cancer:

  • Melanoma

Trial status:

  • Completed
View clinical trial

Liquid biopsy for enhancing patient care through reliable CTC analysis

Get a personalized quote
Request the brochure

Follow ScreenCell on LinkedIn

Subscribe